1α,25-dihydroxyvitamin D3 inhibits rat liver ultrastructural changes and the development of γ-glutamyltranspeptidase-positive foci in diethylnitrosamine-initiated and streptozotocin-induced diabetes-promoted hepatocarcinogenesis

Cell Biochemistry and Function

Volumn 20, Issue 3, 2002, Pages 195-204

  Saha, Barun Kanti ^a   Bhattacharya, Radha ^b   Chatterjee, Malay ^a  

^a JADAVPUR UNIVERSITY   (India)

^b SAHA INSTITUTE OF NUCLEAR PHYSICS   (India)

Author keywords

glutamyltranspeptidase (GGT) positive foci; 1 ,25 dihydroxyvitamin D3; Carcinogenesis; Diethylnitrosamine; Rat liver; Streptozotocin; Ultrastructure

Indexed keywords

CALCITRIOL; DIETHYLNITROSAMINE; GAMMA GLUTAMYLTRANSFERASE; PROPYLENE GLYCOL; STREPTOZOCIN; GLYCOGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ULTRASTRUCTURE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; CYTOARCHITECTURE; DRUG ACTIVITY; DRUG EFFECT; LIVER CARCINOGENESIS; LIVER CELL; LIVER PROTECTION; LIVER STRUCTURE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; VITAMIN SUPPLEMENTATION; ANIMAL; BIOLOGICAL MODEL; BODY WEIGHT; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CYTOPLASM; ELECTRON MICROSCOPY; ENDOPLASMIC RETICULUM; EXPERIMENTAL DIABETES MELLITUS; LIVER; LIVER TUMOR; METABOLISM; ORGAN SIZE; SPRAGUE DAWLEY RAT; TIME; ULTRASTRUCTURE;

ANIMALS; BODY WEIGHT; CALCITRIOL; CYTOPLASM; DIABETES MELLITUS, EXPERIMENTAL; DIETHYLNITROSAMINE; ENDOPLASMIC RETICULUM; GAMMA-GLUTAMYLTRANSFERASE; GLYCOGEN; HEPATOCYTES; LIVER; LIVER NEOPLASMS; MALE; MICROSCOPY, ELECTRON; MODELS, GENETIC; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN; TIME FACTORS;

EID: 0035987417     PISSN: 02636484     EISSN: None     Source Type: Journal    
DOI: 10.1002/cbf.946     Document Type: Article

References (35)

1. Changes in the morphology of induced-liver cancer treated with Strobilanthes crispus
2. The sequential analysis of liver cancer induction
3. A comparison of ultra-structural changes in rat liver due to chemical carcinogens
4. 3 receptors in established human cancer cell lines in culture
5. 3 analogue shows relation to promoter selectivity
6. 3 analogs and their 24-oxo metabolites equally inhibit clonal proliferation of a variety of cancer cells but have differing molecular effects
7. 3 in chemically induced rat colon carcinogenesis
8. Recombinant human GM-CSF enhances the anti-proliferative activity of vitamin-D in MCF-7 human breast cancer clonogenic cells
9. 3
10. 3 in the human prostate carcinoma cell line
11. Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer
12. Risk of endometrial and breast cancer in patients with diabetes mellitus
13. Prospective study of adult onset diabetes mellitus (Type 2) and risk of colorectal cancer
14. Diabetes and endometrial cancer: An Italian case-control study
15. Cancer incidence in a population-base cohort of patients hospitalized with diabetes mellitus in Denmark
16. Excess risk of primary liver cancer in patients with diabetes mellitus
17. Diabetes mellitus and the risk of primary liver cancer
18. 3 inhibit diethylnitrosamine induced rat liver carcinogenesis
19. 3 inhibits rat liver ultrastructural changes in diethylnitrosamine-initiated and phenobarbital promoted rat hepatocarcinogenesis
20. 3 suppresses the effect of streptozotocin-induced diabetes during chemical rat liver carcinogenesis
21. Cellular biochemistry of the stepwise development of cancer with chemicals
22. Inhibitory effect of β-carotene on preneoplastic lesions induced in Wistar rats by the resistant hepatocyte model
23. Histochemical and ultrastructural demonstration of gamma-glutamyltranspeptidase activity
24. Application of quantitative stereology to the evaluation of enzyme altered foci in rat liver
25. The localization by electron microscopy of HeLa cells surface enzymes splitting adenosine triphosphate
26. The use of lead citrate at high pH as an electron opaque stain in electron microscopy
27. The pathogenesis of rat liver cancer caused by chemical carcinogenesis
28. Mechanisms of the inhibition of liver hepatocarcinogenesis promotion by S-adenosyl-L-methionine
29. Rat liver foci bioassay
30. Influence of vitamin D status on the early hepatic response to carcinogen exposure in rats
31. Environmental carcinogenes and anticarcinogens
32. Vitamin D is a membrane antioxidant. Ability to inhibit iron-dependent lipid peroxidation in liposomes compared to cholesterol, ergosterol and tamoxifen and relevance to anticancer action
33. Trans-membrane control of the receptors on normaland malignancy